The Association between Childhood Trauma on Executive Functioning and Treatment Outcomes among Individuals with Methamphetamine Use Disorder.

IF 2.4 4区 医学 Q3 NEUROSCIENCES
Clinical Psychopharmacology and Neuroscience Pub Date : 2025-05-31 Epub Date: 2025-02-21 DOI:10.9758/cpn.24.1248
Cheng-Tsung Lin, Tzu-Yun Wang, Tsung-Yu Tsai, Huai-Hsuan Tseng, Kao Chin Chen, I Hui Lee, Po See Chen, Yen Kuang Yang, Ru-Band Lu
{"title":"The Association between Childhood Trauma on Executive Functioning and Treatment Outcomes among Individuals with Methamphetamine Use Disorder.","authors":"Cheng-Tsung Lin, Tzu-Yun Wang, Tsung-Yu Tsai, Huai-Hsuan Tseng, Kao Chin Chen, I Hui Lee, Po See Chen, Yen Kuang Yang, Ru-Band Lu","doi":"10.9758/cpn.24.1248","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Childhood trauma is associated with executive function impairment and an increased risk of methamphetamine (MA) use. MA use itself also compromises executive function. Limited evidence is known about the association between childhood trauma, executive functioning and treatment outcomes among individuals with MA use disorder (MAUD). The study explored whether patients with MAUD who had experienced childhood trauma presented poorer executive function and treatment outcomes.</p><p><strong>Methods: </strong>The participants were individuals with MAUD and were all recruited from an outpatient-based addiction clinic from 2019 to 2022. Childhood trauma was assessed using Childhood Trauma Questionnaire-Short Form. The Wisconsin Card Sorting Test (WCST), Severity of Dependence Scale (SDS), and Visual Analog Scale for Craving, and urine MA/amphetamine tests were assessed repeatedly during the one-year treatment program. Generalized estimating equations were used to estimate the changes in these outcomes.</p><p><strong>Results: </strong>In 115 MAUD patients we recruited those with a history of childhood physical neglect (PN) exhibited inferior WCST performance on number of categories completed (<i>p</i> = 0.02), and conceptual level responses (<i>p</i> = 0.046) and were more likely to test positive for MA/amphetamine in urine during the one-year treatment (<i>p</i> = 0.02). Patients with PN also reported significantly more severe cravings (<i>p</i> = 0.002), while those with a history of sexual abuse (SA) had notably higher SDS scores (<i>p</i> = 0.004) during treatment.</p><p><strong>Conclusion: </strong>Childhood trauma, particularly PN and SA, shows substantial adverse effects on executive function and treatment outcomes among MAUD patients.</p>","PeriodicalId":10420,"journal":{"name":"Clinical Psychopharmacology and Neuroscience","volume":"23 2","pages":"300-311"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000665/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychopharmacology and Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.9758/cpn.24.1248","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Childhood trauma is associated with executive function impairment and an increased risk of methamphetamine (MA) use. MA use itself also compromises executive function. Limited evidence is known about the association between childhood trauma, executive functioning and treatment outcomes among individuals with MA use disorder (MAUD). The study explored whether patients with MAUD who had experienced childhood trauma presented poorer executive function and treatment outcomes.

Methods: The participants were individuals with MAUD and were all recruited from an outpatient-based addiction clinic from 2019 to 2022. Childhood trauma was assessed using Childhood Trauma Questionnaire-Short Form. The Wisconsin Card Sorting Test (WCST), Severity of Dependence Scale (SDS), and Visual Analog Scale for Craving, and urine MA/amphetamine tests were assessed repeatedly during the one-year treatment program. Generalized estimating equations were used to estimate the changes in these outcomes.

Results: In 115 MAUD patients we recruited those with a history of childhood physical neglect (PN) exhibited inferior WCST performance on number of categories completed (p = 0.02), and conceptual level responses (p = 0.046) and were more likely to test positive for MA/amphetamine in urine during the one-year treatment (p = 0.02). Patients with PN also reported significantly more severe cravings (p = 0.002), while those with a history of sexual abuse (SA) had notably higher SDS scores (p = 0.004) during treatment.

Conclusion: Childhood trauma, particularly PN and SA, shows substantial adverse effects on executive function and treatment outcomes among MAUD patients.

甲基苯丙胺使用障碍个体的童年创伤与执行功能和治疗结果之间的关系。
目的:儿童创伤与执行功能障碍和甲基苯丙胺(MA)使用风险增加有关。MA使用本身也会损害执行功能。关于童年创伤、执行功能和MA使用障碍(MAUD)患者治疗结果之间的关系,目前所知的证据有限。该研究探讨了童年创伤的MAUD患者是否表现出较差的执行功能和治疗结果。方法:参与者是患有MAUD的个体,均从2019年至2022年的门诊成瘾诊所招募。使用《儿童创伤问卷-短表格》评估儿童创伤。威斯康星卡片分类测验(WCST)、依赖严重程度量表(SDS)、渴望视觉模拟量表和尿MA/安非他明测试在一年的治疗方案中反复进行评估。使用广义估计方程来估计这些结果的变化。结果:在115名MAUD患者中,我们招募了那些有儿童身体忽视(PN)史的患者,他们在完成的类别数量(p = 0.02)和概念水平反应(p = 0.046)上表现较差,并且在一年的治疗期间更有可能在尿液中检测出MA/安非他明阳性(p = 0.02)。PN患者也报告了更严重的渴望(p = 0.002),而有性虐待史(SA)的患者在治疗期间的SDS评分明显更高(p = 0.004)。结论:童年创伤,尤其是PN和SA,对MAUD患者的执行功能和治疗结果有显著的不良影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Psychopharmacology and Neuroscience
Clinical Psychopharmacology and Neuroscience NEUROSCIENCESPHARMACOLOGY & PHARMACY-PHARMACOLOGY & PHARMACY
CiteScore
4.70
自引率
12.50%
发文量
81
期刊介绍: Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信